Showing results (81-90 of 154) with videos related to
Sort By:
Pageof 16
Immunotherapy Advances|April 21, 2023
Combination CD200R/PD-1 blockade in a humanised mouse modelMartin Fellermeyer, Consuelo Anzilotti, Christopher Paluch, et al.Immunotherapy Advances|June 27, 2025
Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinomaQintao Ge, Siqi Zhou, Jiahe Lu, et al.Immunotherapy Advances|July 1, 2025
Tumor cell spheroid-induced suppression of primary human cytotoxic T cells as a scalable in vitro model of exhaustionAmal Alsubaiti, Hanin Alamir, Lan Huynh, et al.Immunotherapy Advances|December 25, 2025
Turning the tide: harnessing vaccines and viruses to fight cancerCallum Blee, Munitta Muthana, Greg Wells, et al.Immunotherapy Advances|April 9, 2025
Lung immune challenge study protocol: controlled exposure to inhaled resiquimod (R848) to study mechanisms of inflammationAkhilesh Jha, Marie Fisk, Jamie Forrester, et al.Immunotherapy Advances|May 19, 2025
Intra-tumoural RAMP1+ B cells promote resistance to neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinomaHongyu Zhang, Yuchen Zhang, Pingjing Zhou, et al.Immunotherapy Advances|May 15, 2025
Implementing adjuvant immunotherapy following radical chemoradiotherapy for stage III non-small-cell lung cancer in UK clinical practice-Are the PACIFIC trial outcomes achievable in the real world?Radwa Fawzy Ahmed, Paul Fenton, Adityanarayan Bhatnagar, et al.Immunotherapy Advances|September 12, 2025
Correction to: Applying population mechanistic modelling to find determinants of chimeric antigen receptor T-cells dynamics in month-one lymphoma patientsImmunotherapy Advances|August 4, 2025
SMAC mimetics induce human macrophages to phagocytose live cancer cellsSamantha Y Liu, Max P M Hulsman, Philipp Leyendecker, et al.Immunotherapy Advances|July 5, 2022
Corrigendum to: 100 years post-insulin: immunotherapy as the next frontier in type 1 diabetesPageof 16